Ads
related to: genetic breast cancer gene test- BRCA Test Results
Learn How Different Test Results
Can Affect Your Treatment Plan.
- How Do I Get Tested?
Find Out Next Steps If You're
Ready To Know Your BRCA Status.
- BRCA Mutations
Discover How The BRCA Gene
Can Impact Your Treatment Plan.
- Am I At Risk?
BRCA Mutations Can Be Hereditary.
Talk To Your Family About The Risks
- Answers To FAQs
Read Commonly Asked Questions
To Help Inform Your Treatment Plan.
- Talk To Your Doctor
Download The BRCA Guide To
Help Start The Conversation Today.
- BRCA Test Results
Search results
Results From The WOW.Com Content Network
Most cancer isn't caused by BRCA mutations — they account for 5 percent to 10 percent of breast cancers and 15 percent of ovarian cancers — so the gene tests aren't for everyone. But mutations ...
23andMe DNA Test - Health + Ancestry Personal Genetic Service ($199, Amazon) What is BRCA? While the BRCA gene, known as the "breast cancer gene," is only found in 1 in 400 people and accounts for ...
Hereditary breast cancer along with ovarian cancer syndrome are caused by gene alterations in the genes BRCA1 and BRCA2. Major cancer types related to mutations in these genes are female breast cancer, ovarian, prostate, pancreatic, and male breast cancer. [20] Li-Fraumeni syndrome is caused by a gene alteration on the gene TP53.
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States.Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease.
A patent application for the isolated BRCA1 gene and cancer-cancer promoting mutations discussed above, as well as methods to diagnose the likelihood of getting breast cancer, was filed by the University of Utah, National Institute of Environmental Health Sciences (NIEHS) and Myriad Genetics in 1994; [5] over the next year, Myriad, in ...
Breast and ovarian cancers: Medicare may cover genetic testing to determine if a person has a mutation in the BRCA1 and BRCA2 genes, which can help identify their risk of breast and ovarian cancers.
Ads
related to: genetic breast cancer gene test